wound infection News
-
Preventing Wound Infections and Complications at Urgent Care
Cuts and lacerations are among the most common complaints that bring patients to urgent care clinics. Whether a wound originates from an accident with a sharp object, such as a kitchen knife or yard tool, or from a blunt force such as a fall, there may be a risk of infection. Urgent care providers are responsible for providing treatment that promotes healing and helps prevent wound infection. ...
-
Imbed Biosciences Wins a $2M Award From the U.S. Army to Prevent Combat Wound Infections
Imbed Biosciences, Inc. announced today that it has been awarded a contract for $1,999,481 by the U.S. Army Medical Research and Development Command’s (USAMRDC) Military Infectious Diseases Research Program (MIDRP) to accelerate clinical development of an antibiofilm version of its next-generation Microlyte® Matrix wound dressing that can kill bacteria hidden in biofilms. The contract ...
-
CD BioGlyco Released Separation of Glycosaminoglycans Service Recently
CD BioGlyco, a biotechnology company that provides glycobiology-related products, analysis, custom synthesis, and design to advance glycobiology research, recently announced the release of separation of Separation of Glycosaminoglycans service to the science community. Glycosaminoglycans, once known as mucopolysaccharides, are mainly found in the connective tissues of higher animals and plants. ...
By CD BioGlyco.
-
Aatru Medical Announces FDA Clearance and Commercial Launch of the NPSIMS - Negative Pressure Surgical Incision Management System
Aatru Medical, LLC ("Aatru") today announced U.S. Food and Drug Administration (FDA) 510(k) Class II clearance of the NPSIMS™ Negative Pressure Surgical Incision Management System. The NPSIMS utilizes an innovative mode-of-action that eliminates the expensive electromechanical pump, battery, and electronics found in most other negative pressure wound therapy (NPWT) systems being deployed ...
-
Candida auris and Infection Control Resources for Healthcare Providers
Candida auris is an emerging multidrug-resistant microorganism that was first identified in 2009 in Asia. It has quickly become a cause of severe infections around the world, including in the United States according to the Centers for Disease Control and Prevention (CDC). It is as yeast, which is a type of fungi. CDC describes Candida auris as a concerning drug-resistant fungus because it is: ...
-
XF-73 Dermal infection project advances into clinically enabling safety study with US Government’s NIAID
Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, is pleased to announce the commencement of an Investigational New Drug (IND) enabling safety study with its novel XF-73 Dermal formulation. This study is the second of two planned preclinical safety studies of the XF-73 ...
-
Weekly Donga - EG-Q, Wound Care Liquid Band, Ranked No.1 in Consumer Preference in Korea
EG-Q won the '2022 Korea Consumer Preference No. 1' medical device (liquid band) category. '2022 Korea's No. 1 Consumer Preference' was established to provide consumers with an opportunity to receive verified services and the right selection criteria by discovering and awarding companies, products, and brands that have been verified through fair research. EG-Q is a brand specializing in ...
By Theramx Inc.
-
Aatru Medical Announces Clinical Study and Interim Analysis of their NPSIMS Negative Pressure Surgical Incision Management System
Aatru Medical, LLC ("Aatru") today announced the successful completion of the first 14 patients in their multi-center New Zealand-based clinical study of the FDA-approved NPSIMS™ Negative Pressure Surgical Incision Management System. The full Study enrollment will include plastic surgery, spinal surgery and cardiothoracic surgery closed incisions. The NPSIMS™, which contains no ...
-
Midwest Hospitals on the Lookout for MDR-AB
In November of last year, a new study was published in the American Journal of Infection Control (AJIC). It indicated the common presence of Acinetobacter baumannii (MDR-AB), a dangerous multi-drug resistant bacterium, in numerous patient rooms in healthcare settings. Researchers found that MDR-AB was present in the indoor environment of 48% of the rooms of patients infected or colonized by the ...
-
Candida auris and Infection Control Resources for Healthcare Facilities in Puerto Rico
Several years ago, the Centers for Disease Control and Prevention (CDC) announced it was establishing the Antibiotic Resistance Laboratory Network (AR Lab Network) in Puerto Rico and all 50 states. It was designed to help detect new forms of drug resistance as novel fungal threats emerge. Specifically mentioned in the announcement was Candida auris. CDC reported that this fungus poses a unique ...
-
Healthcare Associated Infection Exposed in New Public Outreach Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. The online video, Acinetobacter, was developed to educate the general public and healthcare providers about this potentially deadly bacterial pathogen often linked with healthcare associated infection (HAIs). Acinetobacter is a group of bacteria commonly found in soil and ...
-
Microbial Outbreak Results in Deaths at Neonatal Intensive Care Unit
Cinnaminson, NJ, August 8th, 2012 The Health Minister of the Bahamas recently ordered an investigation into an outbreak of a microbial pathogen at a neonatal intensive care unit. The outbreak, caused by a type of bacteria known as Acinetobacter baumannii, is believed to have sickened eight infants and caused two of the infants to die. Outbreaks of Acinetobacter baumannii in healthcare ...
-
How is open fracture treated
Usually we will be in the fracture, combined with the coverage of the fracture site of the skin and subcutaneous soft tissue injury fracture, fracture end and the outside of the same fracture called open fracture. Open fracture is faced with commonly the place that suffer an injury is broken, its difficulty rises relatively bigger also, so, how should open fracture be dealt with after all? ...
-
Klebsiella in Healthcare Settings Exposed in New Online Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of another online video to help educate the public about issues that may impact their health. The latest educational video discusses the threat to human health due to the presence of Klebsiella in healthcare environments. Klebsiella is a type of Gram-negative bacteria that can cause different types of healthcare ...
-
Klebsiella in Healthcare Settings Discussed in New Online Video
The IAQ Video Network and Cochrane & Associates announced the release of their latest educational video today. Their newest production discusses Klebsiella, a type of gram-negative bacteria that can cause various healthcare-associated infections (HAIs). “HAIs due to Klebsiella can include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis,” said ...
-
DermBiont Announces Acquisition of SeylanMED to Expand its Portfolio of Targeted Topical Therapeutics Treating Skin Diseases at Their Root Cause
BOSTON, MA, October 21, 2020 – DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded its pipeline and therapeutic modalities with the acquisition of SeylanMED, Inc. “This strategic acquisition delivers multi-factorial value,” said Karl Beutner, MD, PhD, Co-founder, CEO, and CMO of DermBiont. “It expands ...
-
Microbion Corporation Receives up to $2.1 million in Funding Support from the US Navy in Partnership with CUBRC, Inc. to Advance Topical Pravibismane
Microbion Corporation of Bozeman, MT, today announced that it has received non-dilutive funding through its strategic partnership with CUBRC, Inc., a Buffalo-based, independent not-for-profit research company, of up to $2.1 million from the US Navy through the Medical Technology Enterprise Consortium (MTEC) partnership. The funding project is titled “Pravibismane Suspension as a Topical, ...
-
Evaluation of CO2 fractional laser beauty machine treatment effect
The most commonly used fractional laser is CO2 fractional laser beauty machine. After more than ten years of clinical application, it can be said that CO2 fractional laser skin resurfacing treatment technology is relatively safe. As long as its therapeutic energy and action density are mastered, there are generally no obvious side effects of. Bvlaser is a professional CO2 fractional laser ...
-
Infection Control Resources to Identify Klebsiella and Other Pathogens in Healthcare Settings throughout Puerto Rico
The Centers for Disease Control and Prevention (CDC) describes Klebsiella as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs). These include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis. The agency warns Klebsiella bacteria have increasingly developed antimicrobial resistance, most recently to the ...
-
Microbion Corporation Announces Data Highlighting Pravibismane’s Effect on Bacterial Energetics Presented at ASM Microbe 2022
Microbion Corporation today announced that the company presented a poster highlighting the effect of pravibismane on bacterial energetics in Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli and Mycobacterium avium species at ASM Microbe 2022 in Washington, DC. The objectives of these studies were to further understand the mechanism of action of pravibismane, in both planktonic and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you